Skip to Content

AP National Business

European committee: Regulators should deny Merck’s Lagevrio

The Associated Press A European medical committee says regulators should reject Merck’s COVID-19 treatment Lagevrio for European Union use. The drugmaker says a European Medicines Agency committee has recommended marketing authorization refusal for the antiviral pill. More than two dozen countries have already approved or authorized the pill, including the U.S. Merck says it plans

Continue Reading